FOLH1 and Familial prostate cancer: There are several key findings from this work: First, to facilitate our studies, we conducted a detailed characterization of PSMA+ RENCA and RENCA (wt) cells and tumors while comparing with our standard prostate cancer cell lines, PSMA+ PC3 PIP and LNCaP, and PSMA− PC3 flu cells.